Most notable is how the coronavirus issue is having no negative impact.
Until we close under $255, bulls are still very much in charge, and the trend points much higher.
Let's check the charts since our last review.
The 'new' version of NWL is still comprised of a host of well-known brand names after asset sales reduced debt.
The firm's forward guidance is both positive and thoughtful.
Let's go over the charts once again.
No matter what the current price to earnings multiple or enterprise to sales or even out year sales analysis, that sucker's going up.
As investors shrug off the coronavirus headlines and earnings roll in, here's the best stance to take.
This market's bound by earnings and a virus, and both are astonishingly subjective.
TSLA built a plant in China at exactly the worst time in modern Chinese history because of the spreading coronavirus.
You can either get out of the way, or get with it, but I fully endorse PEP as a defensive holding for nervous portfolio managers.
Let's review the earnings reaction to PS and our moves.
PEP could trade sideways for a few days to weeks but the major trend is up.
The inaccurate reporting on PepsiCo's earnings shows why it can be costly to react to the rapid-fire news stories that follow a release.
Updates on the virus are causing another pullback. The question is whether this will lead to a deeper pullback or just another chance to buy the dip.
The stock's decline is likely due to the revenue guidance range for the full year.
This one is all about a lot of risk with a lot of reward.
Here's how to play the high-flying stock after its earnings beat.
CRL has been in a strong technical trend for some time now.
Earnings doubled year-over-year for Sealed Air, yet shares fell, making it a buy.
Here's how to play WU as it heads into earnings later Tuesday -- and why I'd buy based on the chart if it weren't the 'big' day.
Stock looks like it has rebased and is set to try the upside again.
The technical signals for the video game maker suggest its shares may see more price weakness in the weeks and months ahead.
Here are my takes on stocks in biotech and other companies I own right now.
I would lean short (puts) here, but I'm going to opt with a volatility play while also not risking a ton of capital.
The ride sharing company is expected to report earnings on Tuesday after the market close.
If the virus spreads and the shutdown continues, then that time frame will lengthen to at least two quarters.
China-based Alibaba reports quarterly performance Thursday morning. While one might think that an e-commerce type operation could do well in a quarantined environment, it's not quite that easy.
I'm finding little new to do right now as I wonder if the market can continue to ignore the coronavirus issue.
GLW has been an out of favor value name that has not garnered the attention (or returns) of the large tech names.